B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 2978-2988

  Iwata, Hiroaki ^a   Bieber, Katja ^a   Tiburzy, Benjamin ^a   Chrobok, Navina ^a   Kalies, Kathrin ^a   Shimizu, Atsushi ^b   Leineweber, Sarah ^a   Ishiko, Akira ^b   Vorobyev, Artem ^a   Zillikens, Detlef ^a   Köhl, Jörg ^a,c   Westermann, Jürgen ^a   Seeger, Karsten ^a   Manz, Rudolf ^a   Ludwig, Ralf J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b TOHO UNIVERSITY   (Japan)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; COMPLEMENT COMPONENT C3; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BLISTER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MALE; MOUSE; NONCOLLAGENOUS DOMAIN 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; T CELL DEPLETION; TH1 CELL; VON WILLEBRAND FACTOR A LIKE DOMAIN 2;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; COLLAGEN TYPE VII; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; EXTRACELLULAR MATRIX PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; PROTEIN STRUCTURE, TERTIARY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84884218068     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300310     Document Type: Article

References (58)

1. Van de Keere, F., and S. Tonegawa. 1998. CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J. Exp. Med. 188: 1875-1882.
2. Makhlouf, L., S. T. Grey, V. Dong, E. Csizmadia, M. B. Arvelo, H. Auchincloss, Jr., C. Ferran, and M. H. Sayegh. 2004. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation 77: 990-997.
3. Wen, Z., L. Xu, W. Xu, and S. Xiong. 2012. Production of anti-double-stranded DNA antibodies in activated lymphocyte derived DNA induced lupus model was dependent on CD4+ T cells. Lupus 21: 508-516.
4. Stanley, J. R., and M. Amagai. 2006. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N. Engl. J. Med. 355: 1800-1810.
5. Schmidt, E., and D. Zillikens. 2013. Pemphigoid diseases. Lancet 381: 320-332.
6. Ludwig, R. J. 2013. Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol. 2013: 812029.
7. Anhalt, G. J., R. S. Labib, J. J. Voorhees, T. F. Beals, and L. A. Diaz. 1982. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306: 1189-1196.
8. Liu, Z., L. A. Diaz, J. L. Troy, A. F. Taylor, D. J. Emery, J. A. Fairley, and G. J. Giudice. 1993. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J. Clin. Invest. 92: 2480-2488.
9. Lazarova, Z., C. Yee, T. Darling, R. A. Briggaman, and K. B. Yancey. 1996. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J. Clin. Invest. 98: 1509-1518.
10. Sitaru, C., S. Mihai, C. Otto, M. T. Chiriac, I. Hausser, B. Dotterweich, H. Saito, C. Rose, A. Ishiko, and D. Zillikens. 2005. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J. Clin. Invest. 115: 870-878.
11. Woodley, D. T., C. Chang, P. Saadat, R. Ram, Z. Liu, and M. Chen. 2005. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J. Invest. Dermatol. 124: 958-964.
12. Chen, M., A. Doostan, P. Bandyopadhyay, J. Remington, X. Wang, Y. Hou, Z. Liu, and D. T. Woodley. 2007. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am. J. Pathol. 170: 2009-2018.
13. Nishie, W., D. Sawamura, M. Goto, K. Ito, A. Shibaki, J. R. McMillan, K. Sakai, H. Nakamura, E. Olasz, K. B. Yancey, et al. 2007. Humanization of autoantigen. Nat. Med. 13: 378-383.
14. Amagai, M., K. Tsunoda, H. Suzuki, K. Nishifuji, S. Koyasu, and T. Nishikawa. 2000. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J. Clin. Invest. 105: 625-631.
15. Ujiie, H., A. Shibaki, W. Nishie, D. Sawamura, G. Wang, Y. Tateishi, Q. Li, R. Moriuchi, H. Qiao, H. Nakamura, et al. 2010. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen. J. Immunol. 184: 2166-2174.
16. Takahashi, H., M. Amagai, T. Nishikawa, Y. Fujii, Y. Kawakami, and M. Kuwana. 2008. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. J. Immunol. 181: 1526-1535.
17. Takahashi, H., M. Kuwana, and M. Amagai. 2009. A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris. J. Immunol. 182: 1740-1745.
18. Ujiie, H., and H. Shimizu. 2012. Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models. Exp. Dermatol. 21: 901-905.
19. Marietta, E., K. Black, M. Camilleri, P. Krause, R. S. Rogers, III, C. David, M. R. Pittelkow, and J. A. Murray. 2004. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J. Clin. Invest. 114: 1090-1097.
20. Sitaru, C., M. T. Chiriac, S. Mihai, J. Büning, A. Gebert, A. Ishiko, and D. Zillikens. 2006. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J. Immunol. 177: 3461-3468.
21. Hirose, M., A. Recke, T. Beckmann, A. Shimizu, A. Ishiko, K. Bieber, J. Westermann, D. Zillikens, E. Schmidt, and R. J. Ludwig. 2011. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice. J. Immunol. 187: 1176-1183.
22. Ludwig, R. J., A. Recke, K. Bieber, S. Müller, Ade. C. Marques, D. Banczyk, M. Hirose, M. Kasperkiewicz, N. Ishii, E. Schmidt, et al. 2011. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. J. Invest. Dermatol. 131: 167-176.
23. Sitaru, A. G., A. Sesarman, S. Mihai, M. T. Chiriac, D. Zillikens, P. Hultman, W. Solbach, and C. Sitaru. 2010. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita. J. Immunol. 184: 1596-1603.
24. Ludwig, R. J., K. Kalies, J. Kö hl, D. Zillikens, and E. Schmidt. 2013. Emerging treatments for pemphigoid diseases. Trends Mol. Med. DOI: 10.1016/j.molmed. 2013.06.003.
25. Woodley, D. T., R. A. Briggaman, E. J. O'Keefe, A. O. Inman, L. L. Queen, and W. R. Gammon. 1984. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N. Engl. J. Med. 310: 1007-1013.
26. Woodley, D. T., R. E. Burgeson, G. Lunstrum, L. Bruckner-Tuderman, M. J. Reese, and R. A. Briggaman. 1988. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J. Clin. Invest. 81: 683-687.
27. Lunstrum, G. P., L. Y. Sakai, D. R. Keene, N. P. Morris, and R. E. Burgeson. 1986. Large complex globular domains of type VII procollagen contribute to the structure of anchoring fibrils. J. Biol. Chem. 261: 9042-9048.
28. Lunstrum, G. P., H. J. Kuo, L. M. Rosenbaum, D. R. Keene, R. W. Glanville, L. Y. Sakai, and R. E. Burgeson. 1987. Anchoring fibrils contain the carboxylterminal globular domain of type VII procollagen, but lack the amino-terminal globular domain. J. Biol. Chem. 262: 13706-13712.
29. Gammon, W. R., M. L. Abernethy, K. M. Padilla, P. S. Prisayanh, M. E. Cook, J. Wright, R. A. Briggaman, and S. W. Hunt, III. 1992. Noncollagenous (NC1) domain of collagen VII resembles multidomain adhesion proteins involved in tissue-specific organization of extracellular matrix. J. Invest. Dermatol. 99: 691-696.
30. Villone, D., A. Fritsch, M. Koch, L. Bruckner-Tuderman, U. Hansen, and P. Bruckner. 2008. Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils. J. Biol. Chem. 283: 24506-24513.
31. Wegener, H., S. Leineweber, and K. Seeger. 2013. The vWFA2 domain of type VII collagen is responsible for collagen binding. Biochem. Biophys. Res. Commun. 430: 449-453.
32. Lapiere, J. C., D. T. Woodley, M. G. Parente, T. Iwasaki, K. C. Wynn, A. M. Christiano, and J. Uitto. 1993. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J. Clin. Invest. 92: 1831-1839.
33. Leineweber, S., S. Schönig, and K. Seeger. 2011. Insight into interactions of the von-Willebrand-factor-A-like domain 2 with the FNIII-like domain 9 of collagen VII by NMR and SPR. FEBS Lett. 585: 1748-1752.
34. Zillikens, D., Y. Kawahara, A. Ishiko, H. Shimizu, J. Mayer, C. V. Rank, Z. Liu, G. J. Giudice, H. H. Tran, M. P. Marinkovich, et al. 1996. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J. Invest. Dermatol. 106: 1333-1338.
35. Zillikens, D., K. Herzele, M. Georgi, E. Schmidt, I. Chimanovitch, H. Schumann, J. M. Mascaro, Jr., L. A. Diaz, L. Bruckner-Tuderman, E. B. Bröcker, and G. J. Giudice. 1999. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. J. Invest. Dermatol. 113: 947-953.
36. Mochimaru, H., T. Usui, T. Yaguchi, Y. Nagahama, G. Hasegawa, Y. Usui, S. Shimmura, K. Tsubota, S. Amano, Y. Kawakami, and S. Ishida. 2008. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Invest. Ophthalmol. Vis. Sci. 49: 2172-2177.
37. Schmidt, N. W., N. S. Butler, V. P. Badovinac, and J. T. Harty. 2010. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog. 6: e1000998.
38. Delemarre, F. G., N. Kors, G. Kraal, and N. van Rooijen. 1990. Repopulation of macrophages in popliteal lymph nodes of mice after liposome-mediated depletion. J. Leukoc. Biol. 47: 251-257.
39. Hammers, C. M., K. Bieber, K. Kalies, D. Banczyk, C. T. Ellebrecht, S.M. Ibrahim, D. Zillikens, R. J. Ludwig, and J. Westermann. 2011. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice. J. Immunol. 187: 5043-5050.
40. Gupta, R., D. T. Woodley, and M. Chen. 2012. Epidermolysis bullosa acquisita. Clin. Dermatol. 30: 60-69.
41. Gammon, W. R., E. R. Heise, W. A. Burke, J. D. Fine, D. T. Woodley, and R. A. Briggaman. 1988. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J. Invest. Dermatol. 91: 228-232.
42. Zumelzu, C., C. Le Roux-Villet, P. Loiseau, M. Busson, M. Heller, F. Aucouturier, V. Pendaries, N. Lièvre, F. Pascal, M.-D. Brette, et al. 2011. Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. J. Invest. Dermatol. 131: 2386-2393.
43. Ludwig, R. J., S. Müller, Ad. Marques, A. Recke, E. Schmidt, D. Zillikens, S. Möller, and S. M. Ibrahim. 2012. Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita. J. Invest. Dermatol. 132: 1409-1415.
44. Linker-Israeli, M., F. P. Quismorio, Jr., and D. A. Horwitz. 1990. CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arthritis Rheum. 33: 1216-1225.
45. Merino, J., S. Schurmans, L. Wen, G. Brighouse, S. Luzuy, and P. H. Lambert. 1990. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: analysis of the role of donor T cells in the induction of autoimmunity. Clin. Exp. Immunol. 79: 273-278.
46. Saitoh, O., N. Abiru, M. Nakahara, and Y. Nagayama. 2007. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model. Endocrinology 148: 6040-6046.
47. Hussell, T., C. J. Baldwin, A. O'Garra, and P. J. Openshaw. 1997. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27: 3341-3349.
48. Sosroseno, W., P. S. Bird, E. Gemmell, and G. J. Seymour. 2006. The role of CD4+ and CD8+ T cells on antibody production by murine Peyer's patch cells following mucosal presentation of Actinomyces viscosus. Oral Microbiol. Immunol. 21: 411-414.
49. Chen, X., and P. E. Jensen. 2008. The role of B lymphocytes as antigenpresenting cells. Arch. Immunol. Ther. Exp. (Warsz.) 56: 77-83.
50. Catchpole, B., N. A. Staines, and A. S. Hamblin. 2001. Antigen presentation of Type II collagen in rats. Clin. Exp. Immunol. 125: 478-484.
51. Zhao, W., Z. Zhao, and M. W. Russell. 2011. Characterization of antigenpresenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins. Mol. Oral Microbiol. 26: 200-209.
52. Gilbert, M. R., N. J. Wagner, S. Z. Jones, A. B. Wisz, J. R. Roques, K. N. Krum, S.-R. Lee, V. Nickeleit, C. Hulbert, J. W. Thomas, et al. 2012. Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages. J. Immunol. 189: 711-720.
53. Zillikens, D., P. A. Rose, S. D. Balding, Z. Liu, M. Olague-Marchan, L. A. Diaz, and G. J. Giudice. 1997. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J. Invest. Dermatol. 109: 573-579.
54. Gammon, W. R., D. F. Murrell, M. W. Jenison, K. M. Padilla, P. S. Prisayanh, D. A. Jones, R. A. Briggaman, and S. W. Hunt, III. 1993. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J. Invest. Dermatol. 100: 618-622.
55. Tanaka, T., F. Furukawa, and S. Imamura. 1994. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J. Invest. Dermatol. 102: 706-709.
56. Jones, D. A., S. W. Hunt, III, P. S. Prisayanh, R. A. Briggaman, and W. R. Gammon. 1995. Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J. Invest. Dermatol. 104: 231-235.
57. Chen, M., D. R. Keene, F. K. Costa, S. H. Tahk, and D. T. Woodley. 2001. The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies. J. Biol. Chem. 276: 21649-21655.
58. Ishii, N., M. Yoshida, Y. Hisamatsu, A. Ishida-Yamamoto, H. Nakane, H. Iizuka, T. Tanaka, and T. Hashimoto. 2004. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br. J. Dermatol. 150: 843-851.